renal cancer andadrenal tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age ranging from 18 to 85 years without gender restriction; patients diagnosed with unilateral renal tumor accompanied by ipsilateral adrenal tumor via computed tomography (CT) or magnetic resonance imaging (MRI). 2.Clinical stage eligible for partial nephrectomy (cT1–T2 renal tumors); adrenal tumors meeting surgical indications (adenoma, pheochromocytoma). 3.Receipt of one-stage combined robotic-assisted laparoscopic partial nephrectomy plus ipsilateral adrenal tumorectomy. 4.Complete clinical, perioperative, pathological and follow-up data available.
Exclusion criteria
Exclusion criteria: 1.Patients requiring radical nephrectomy instead of partial nephrectomy. 2.Patients with advanced stage/grade disease (renal tumor = cT3, extensively invasive malignant adrenal tumors) unsuitable for safe simultaneous resection. 3.Suspected malignant adrenal tumors. 4.Patients with severe cardiac, pulmonary, hepatic or renal dysfunction intolerant to anesthesia and surgery. 5.Presence of high-risk factors including coagulation disorders, active hemorrhage, and uncontrolled infection. 6.Patients with severely missing clinical data, loss to follow-up, or unavailable efficacy evaluation. 7.Patients with prior surgical history on the ipsilateral kidney or adrenal gland that interferes with outcome assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimated blood loss;Postoperative complications;Warm Ischemia Time;renal function;operation time;Postoperative hospital stay; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological findings;postoperative followup;Surgical approach;basic data of the patients; | — |
Countries
China
Contacts
The First Affiliated Hospital of Chongqing Medical University